RabGEF1 is a negative regulator of mast cell activation and skin inflammation

See-Ying Tam1, Mindy Tsai, John N Snouwaert

  • 1Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA. stam@stanford.edu

Nature Immunology
|July 6, 2004
PubMed

Insights

RabGEF1 negatively regulates mast cell activation. Its absence leads to enhanced degranulation, mediator release, and severe skin inflammation in mice, highlighting its role in immune response.

Area of Science:

  • Immunology
  • Cell Biology
  • Dermatology

Background:

  • Mast cell activation is crucial in allergic responses and inflammation.
  • Fc epsilon RI receptor aggregation triggers intracellular signaling cascades, including protein kinases.
  • The precise regulators of these pathways are not fully understood.

Purpose of the Study:

  • To investigate the role of the regulatory protein RabGEF1 in Fc epsilon RI-dependent mast cell activation.
  • To determine the in vivo consequences of RabGEF1 deficiency in mast cell-mediated responses.

Main Methods:

  • Utilized mast cells and mouse models deficient in RabGEF1.
  • Assessed mast cell degranulation and mediator release.
  • Analyzed skin inflammation and mast cell infiltration in vivo.

Main Results:

  • RabGEF1 directly binds to Ras, negatively regulating its activation.
  • RabGEF1-deficient mast cells exhibit heightened degranulation and release of inflammatory mediators.
  • RabGEF1-deficient mice display severe skin inflammation with increased mast cell populations.

Conclusions:

  • RabGEF1 acts as a critical negative regulator of Fc epsilon RI-mediated mast cell activation.
  • Loss of RabGEF1 function promotes inflammatory responses and contributes to skin inflammation.
  • Targeting RabGEF1 may offer therapeutic potential for inflammatory skin diseases.

Related Concept Videos

Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...